Amneal Pharmaceuticals AMRX
NASDAQ AMRX
$21.23 -0.15 (-0.70%)
At close: Nov 16, 2026 · 4:00 PM EST

Amneal Pharmaceuticals (AMRX) Liabilities and Shareholders Equity (2017 - 2026)

Updated

Amneal Pharmaceuticals' Liabilities and Shareholders Equity was $5.27 billion in Q3 2026, up 46.3% from $3.6 billion a year earlier and up 39.5% from the prior quarter.

Analysis

Amneal Pharmaceuticals (AMRX) Liabilities and Shareholders Equity (2017 - 2026) Analysis & Trends

At the end of FY2025, Liabilities and Shareholders Equity at Amneal Pharmaceuticals came in at $3.68 billion, up 5.1% from FY2024.

  • Liabilities and Shareholders Equity shows a five-year compound annual growth rate of -1.7% (FY2020 to FY2025).
  • In earlier years, Liabilities and Shareholders Equity was $3.5 billion in FY2024 (+0.8%), $3.47 billion in FY2023 (-8.6%), $3.8 billion in FY2022 (-3.6%) and $3.94 billion in FY2021 (-1.7%).
  • The Q3 2026 figure marks the highest quarterly Liabilities and Shareholders Equity in data going back to Q4 2017.
  • Compared with a year earlier, Liabilities and Shareholders Equity has increased for five straight quarters, with growth averaging 8.3% over the last eight quarters.
  • The best year-over-year quarter for Liabilities and Shareholders Equity over five years was Q3 2026 (growth of 46.3%); the worst was Q4 2023 (a decline of 8.6%).
  • Per Business Quant data, AMRX's Liabilities and Shareholders Equity in the three quarters before Q3 2026 was $3.78 billion (Q2 2026), $3.54 billion (Q1 2026) and $3.68 billion (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 197.43 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 147.68 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 132.77 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 119.92 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 96.05 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 51.41 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 205.00 Bn
10 Amneal Pharmaceuticals 7.10 Bn 6.33 Bn 334.12 Mn 5.27 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 5.27 Bn
Jun 30, 2026 3.78 Bn
Mar 31, 2026 3.54 Bn
Dec 31, 2025 3.68 Bn
Sep 30, 2025 3.60 Bn
Jun 30, 2025 3.42 Bn
Mar 31, 2025 3.37 Bn
Dec 31, 2024 3.50 Bn
Sep 30, 2024 3.46 Bn
Jun 30, 2024 3.51 Bn
Mar 31, 2024 3.46 Bn
Dec 31, 2023 3.47 Bn
Sep 30, 2023 3.69 Bn
Jun 30, 2023 3.70 Bn
Mar 31, 2023 3.63 Bn
Dec 31, 2022 3.80 Bn
Sep 30, 2022 3.87 Bn
Jun 30, 2022 4.04 Bn
Mar 31, 2022 3.89 Bn
Dec 31, 2021 3.94 Bn
API Access

Amneal Pharmaceuticals Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=AMRX&period=max&api_key=YOUR_API_KEY